For many years, the most commonly used medicine to treat Type 2 diabetes has been metformin. It helps keep blood sugar levels ...

In a major breakthrough for diabetes treatment, scientists have found a new way to regenerate insulin-producing cells. This ...

Eli Lilly and Co., the maker of Zepbound and Mounjaro, announced a successful Phase 3 trial for a once-daily GLP-1 pill for ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

The ‘4S’ Pathway was designed to guide shifting needs in older adults with diabetes who are struggling with diabetes ...

The latest statistics show 38 million adults in the United States have diabetes and almost half those people don’t even know ...

Eligible participants were aged 50 and over, had a diagnosis of tT2D, and no prior history of dementia or use of ...

Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...

A large population-based study found that GLP-1 receptor agonists (GLP-1RAs) and SGLT2 inhibitors (SGLT2is), two classes of ...

2025 — Nearly 40% of patients diagnosed with type 2 diabetes imperil their health by stopping their medication within the first year, diabetes experts ... Mar. 27, 2025 — A research team has ...